1. Home
  2. AERT vs RNXT Comparison

AERT vs RNXT Comparison

Compare AERT & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AERT
  • RNXT
  • Stock Information
  • Founded
  • AERT 2012
  • RNXT 2012
  • Country
  • AERT Singapore
  • RNXT United States
  • Employees
  • AERT N/A
  • RNXT N/A
  • Industry
  • AERT Professional Services
  • RNXT Biotechnology: Pharmaceutical Preparations
  • Sector
  • AERT Consumer Discretionary
  • RNXT Health Care
  • Exchange
  • AERT Nasdaq
  • RNXT Nasdaq
  • Market Cap
  • AERT 37.6M
  • RNXT 44.6M
  • IPO Year
  • AERT N/A
  • RNXT 2021
  • Fundamental
  • Price
  • AERT $0.88
  • RNXT $0.94
  • Analyst Decision
  • AERT
  • RNXT Strong Buy
  • Analyst Count
  • AERT 0
  • RNXT 2
  • Target Price
  • AERT N/A
  • RNXT $7.25
  • AVG Volume (30 Days)
  • AERT 7.0M
  • RNXT 191.0K
  • Earning Date
  • AERT 08-14-2025
  • RNXT 08-14-2025
  • Dividend Yield
  • AERT N/A
  • RNXT N/A
  • EPS Growth
  • AERT N/A
  • RNXT N/A
  • EPS
  • AERT N/A
  • RNXT N/A
  • Revenue
  • AERT $68,861,000.00
  • RNXT $662,000.00
  • Revenue This Year
  • AERT N/A
  • RNXT $3,104.65
  • Revenue Next Year
  • AERT N/A
  • RNXT $301.89
  • P/E Ratio
  • AERT N/A
  • RNXT N/A
  • Revenue Growth
  • AERT N/A
  • RNXT N/A
  • 52 Week Low
  • AERT $0.46
  • RNXT $0.75
  • 52 Week High
  • AERT $2.80
  • RNXT $1.69
  • Technical
  • Relative Strength Index (RSI)
  • AERT 48.96
  • RNXT 30.26
  • Support Level
  • AERT $0.73
  • RNXT $1.23
  • Resistance Level
  • AERT $1.15
  • RNXT $1.37
  • Average True Range (ATR)
  • AERT 0.14
  • RNXT 0.09
  • MACD
  • AERT 0.01
  • RNXT -0.03
  • Stochastic Oscillator
  • AERT 30.09
  • RNXT 10.23

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: